Annual CAPEX
$2.77 M
-$8.77 M-75.98%
December 31, 2023
Summary
- As of February 28, 2025, FDMT annual capital expenditures is $2.77 million, with the most recent change of -$8.77 million (-75.98%) on December 31, 2023.
- During the last 3 years, FDMT annual CAPEX has risen by +$1.77 million (+177.10%).
- FDMT annual CAPEX is now -75.98% below its all-time high of $11.54 million, reached on December 31, 2022.
Performance
FDMT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$1.78 M
+$1.43 M+409.46%
September 30, 2024
Summary
- As of February 28, 2025, FDMT quarterly capital expenditures is $1.78 million, with the most recent change of +$1.43 million (+409.46%) on September 30, 2024.
- Over the past year, FDMT quarterly CAPEX has increased by +$1.37 million (+339.01%).
- FDMT quarterly CAPEX is now -72.28% below its all-time high of $6.41 million, reached on March 31, 2022.
Performance
FDMT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$3.39 M
+$1.37 M+68.21%
September 30, 2024
Summary
- As of February 28, 2025, FDMT TTM capital expenditures is $3.39 million, with the most recent change of +$1.37 million (+68.21%) on September 30, 2024.
- Over the past year, FDMT TTM CAPEX has increased by +$71.00 thousand (+2.14%).
- FDMT TTM CAPEX is now -79.11% below its all-time high of $16.21 million, reached on June 30, 2022.
Performance
FDMT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
FDMT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.0% | +339.0% | +2.1% |
| 3 y3 years | +177.1% | +339.0% | +2.1% |
| 5 y5 years | +569.3% | +339.0% | +2.1% |
FDMT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -76.0% | at low | -72.3% | +409.5% | -79.1% | +68.2% |
| 5 y | 5-year | -76.0% | +177.1% | -72.3% | +609.5% | -79.1% | +588.2% |
| alltime | all time | -76.0% | +569.3% | -72.3% | +609.5% | -79.1% | +588.2% |
4D Molecular Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.78 M(+409.5%) | $3.39 M(+68.2%) |
| Jun 2024 | - | $349.00 K(-50.8%) | $2.01 M(-18.5%) |
| Mar 2024 | - | $710.00 K(+29.3%) | $2.47 M(-10.9%) |
| Dec 2023 | $2.77 M(-76.0%) | $549.00 K(+35.6%) | $2.77 M(-16.4%) |
| Sep 2023 | - | $405.00 K(-49.7%) | $3.31 M(-32.0%) |
| Jun 2023 | - | $805.00 K(-20.5%) | $4.87 M(-20.6%) |
| Mar 2023 | - | $1.01 M(-7.4%) | $6.13 M(-46.8%) |
| Dec 2022 | $11.54 M(+26.6%) | $1.09 M(-44.3%) | $11.54 M(-25.8%) |
| Sep 2022 | - | $1.96 M(-4.9%) | $15.54 M(-4.1%) |
| Jun 2022 | - | $2.07 M(-67.8%) | $16.21 M(+8.9%) |
| Mar 2022 | - | $6.41 M(+25.8%) | $14.88 M(+63.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $9.11 M(+811.0%) | $5.10 M(+93.4%) | $9.11 M(+101.5%) |
| Sep 2021 | - | $2.63 M(+257.5%) | $4.52 M(+194.0%) |
| Jun 2021 | - | $737.00 K(+14.8%) | $1.54 M(+67.0%) |
| Mar 2021 | - | $642.00 K(+26.4%) | $921.00 K(-7.9%) |
| Dec 2020 | $1.00 M(-68.8%) | $508.00 K(-245.6%) | $1.00 M(+103.3%) |
| Sep 2020 | - | -$349.00 K(-390.8%) | $492.00 K(-41.5%) |
| Jun 2020 | - | $120.00 K(-83.4%) | $841.00 K(+16.6%) |
| Mar 2020 | - | $721.00 K | $721.00 K |
| Dec 2019 | $3.20 M(+673.7%) | - | - |
| Dec 2018 | $414.00 K(-27.7%) | - | - |
| Dec 2017 | $573.00 K | - | - |
FAQ
- What is 4D Molecular Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual CAPEX year-on-year change?
- What is 4D Molecular Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly CAPEX year-on-year change?
- What is 4D Molecular Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM CAPEX year-on-year change?
What is 4D Molecular Therapeutics annual capital expenditures?
The current annual CAPEX of FDMT is $2.77 M
What is the all time high annual CAPEX for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual capital expenditures is $11.54 M
What is 4D Molecular Therapeutics annual CAPEX year-on-year change?
Over the past year, FDMT annual capital expenditures has changed by -$8.77 M (-75.98%)
What is 4D Molecular Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of FDMT is $1.78 M
What is the all time high quarterly CAPEX for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly capital expenditures is $6.41 M
What is 4D Molecular Therapeutics quarterly CAPEX year-on-year change?
Over the past year, FDMT quarterly capital expenditures has changed by +$1.37 M (+339.01%)
What is 4D Molecular Therapeutics TTM capital expenditures?
The current TTM CAPEX of FDMT is $3.39 M
What is the all time high TTM CAPEX for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM capital expenditures is $16.21 M
What is 4D Molecular Therapeutics TTM CAPEX year-on-year change?
Over the past year, FDMT TTM capital expenditures has changed by +$71.00 K (+2.14%)